Madrigal Pharmaceuticals, Inc. (MDGL)
Madrigal Pharmaceuticals Market Cap : 11.96B for May 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insmed, Inc. | 23.11B |
| ACADIA Pharmaceuticals, Inc. | 3.682B |
| PTC Therapeutics, Inc. | 5.926B |
| Protagonist Therapeutics, Inc. | 6.652B |
| Altimmune, Inc. | 549.39M |
Market Cap Related Metrics
| PS Ratio | 11.05 |
| Price to Book Value | 22.00 |
| Price | 518.62 |
| Earnings Yield | -2.47% |